CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing studyManabu Funayama, Nobutaka Hattori, Maya Ando et al.|The Lancet Neurology|2015Cited by 359
Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s diseaseShinji Saiki, Nobutaka Hattori, Taku Hatano et al.|Scientific Reports|2017Cited by 143
A metabolic profile of polyamines in parkinson disease: A promising biomarkerShinji Saiki, Nobutaka Hattori, Yukiko Sasazawa et al.|Annals of Neurology|2019Cited by 123
Iron Supply via NCOA4-Mediated Ferritin Degradation Maintains Mitochondrial FunctionsMotoki Fujimaki, Nobutaka Hattori, Norihiko Furuya et al.|Molecular and Cellular Biology|2019Cited by 84